(2010). First report of a randomized phase II trial of multi- epitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells in patients with metastatic melanoma: An Eastern Cooperative Oncology Group Study (E1602) [abstract]. J Clin Oncol 28(15s): 8508.